Skip to content

Peripheral Metabolic Function in Chronic Heart Failure Patients

Peripheral Metabolic Function in Chronic Heart Failure Patients: Key to Lessen the Cardiac Load

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02732990
Enrollment
60
Registered
2016-04-11
Start date
2014-02-28
Completion date
2016-08-31
Last updated
2016-04-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Heart Failure

Keywords

Training, One-legged exercise, Peripheral blood flow, Cardiac function, Muscle metaboreflex

Brief summary

Exercise intolerance is a major limiting symptom in patients with CHF. However the poor correlation between the hemodynamic parameters of left ventricular performance at rest and exercise performance has led to the concept that peripheral factors such as muscle perfusion and muscle metabolism play a role as determinants of exercise capacity.

Detailed description

The pathophysiology behind the breathlessness and fatigue experienced by CHF patients during exercise remains unclear. Recent evidence suggests that the peripheral skeletal muscle, which becomes abnormal in heart failure, is the source of afferent signals which disrupt normal patterns of cardiorespiratory control. When CHF patients exercise, an inappropriately strong sympathetic response further limits exercise tolerance by evoking larger than normal increases in peripheral sympathetic activation at a faster rate than in healthy individuals. A consequence of this exacerbated sympathetic response may be the further sympathetic restraint of blood flow to the active skeletal muscles resulting in hypoperfusion of the muscle vascular bed and fatigue. Small muscle mass exercise training increases muscle oxidative capacity and improves aerobic work capacity in CHF patients. A range of studies is proposed here that will provide an integrative view of the mechanistic basis behind exercise intolerance in CHF and relate the intramuscular metabolic status to the autonomic control of hemodynamics during exercise. An understanding of the mechanistic basis of the improved exercise tolerance with training, independent of improved resting cardiac function, will yield important information regarding the integrated control of blood flow and metabolic demand in CHF and highlight the importance of maintaining the integrity of the peripheral musculature in CHF.

Interventions

BEHAVIORALExercise training

All gruoups will undergo 6 weeks of training intervention either with a small musclemass (one-legged exercise) or whole body exercise (two-legged cycling)

Sponsors

Anders Rasmussen Rinnov
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
HEALTH_SERVICES_RESEARCH
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
40 Years to 70 Years
Healthy volunteers
Yes

Inclusion criteria

* New York Heart Association (NYHA) Class II - III * Ejection fraction \<35% * Heart failure as a result of previous myocardial infarction * Optimal treatment (ACE-inhibitors, beta-blockers) * Stable heart failure * Patients with and without implantable cardioverter defibrillator (ICD)

Exclusion criteria

* Peripheral vascular disease with symptoms of atherosclerosis (intermittent claudication) * Aneurysm in a. femoral * Moderate to severe heart valve disease * Moderate to severe Chronic Obstructive Pulmonary Disease (COPD) with FEV1 \<60% * Heart Failure Patients with Biventricular pacemaker (BVP) * Serious heart rhythm disturbances (arrhythmias such as atrial fibrillation and frequent premature ventricular contractions) * Myocardial infarction within the last month * Unstable angina (angina pectoris) * Renal failure (creatinine greater than 2.5 mg / dL) * Severe systemic disease of the nervous system, pulmonary or other severe organ involvement * BMI\> 30 * Pregnancy

Design outcomes

Primary

MeasureTime frameDescription
Change from baseline sympathetic nerve activity after 6 weeks of training6 weeksSympathetic nerve activity, measured in plasma and dialysat with reference to nor-adrenaline.

Secondary

MeasureTime frameDescription
The effect of exercise training on exercise capacity in regards to oxygen uptake6 weeksExercise capacity in regards to oxygen uptake (VO2peak) will be evaluated before and after the training intervention
The effect of exercise training on exercise capacity in regards to maximal workload6 weeksExercise capacity in regards to Workload during 2-legged cycling (Wattpeak) will be evaluated before and after the training intervention
The effect of exercise training on exercise capacity in regards to a 6 min walk test6 weeksExercise capacity in regards to a 6 min walk test (meters) will be evaluated before and after the training intervention

Countries

Denmark

Contacts

Primary ContactGregers W Munch, MSc PhD
gregers.munch@regionh.dk+45 35459574

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026